Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
Live Science on MSN4d
How does rowing affect your heart, and is it different to running?Rowing machines and treadmills do not challenge your cardiovascular system in the same way, so what is the science behind it?
China: A recent study highlights the potential risks associated with sarcopenic obesity (SO) in diabetic patients with heart ...
Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...
Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.
The following is a summary of "Engineering approach to study the effect of TEVAR on the cardiovascular system: A systematic ...
Berlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback